Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Jefferies Healthcare Conference Transcript

Jun 05, 2019 / 12:30PM GMT
Release Date Price: $127.59 (+0.85%)
Unidentified Analyst

Hi, good morning. Sorry for the delay. Get ourselves rolling here in the second session. Anyways, good morning. Here at Jefferies Healthcare Conference. Appreciate your attendance and support. Our next company presenting is Charles River Laboratories. Here with me to participate in our fireside chat is David Smith, the company's Executive Vice President and Chief Financial Officer.

Questions & Answers

Unidentified Analyst

So David, I'm going to start, kind of like I always start -- like to start at the top line and the income statement, talk about demand a little bit. Can you -- we've heard the management, yourself and Jim Foster, the CEO, talk about the strength of the demand environment. Could you kind of put some color around that and maybe walk us through demand, in general, and how it varies, if at all, across the 3 segments?

David Ross Smith
Charles River Laboratories International, Inc. - Corporate Executive VP & CFO

So the demand is extremely good at the moment, which is characterized

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot